RIÑÓN Y ENFERMEDAD CARDIOVASCULAR - Seden

BIBLIOGRAFÍA
521. Bologa RM, Levine DM, Parker TS, Cheigh JS, Serur D,
Stenzel KH y cols. Interleukin-6 predicts hypoalbuminemia,
hypocholesterolemia, and mortality in hemodialysis
patients. Am J Kidney Dis 32: 469-76, 1998.
522. Kalantar-Zadeh K, Kopple JD, Humphreys MH, Block
G.Comparing outcome predictability of markers of malnutrition–inflammation
complex syndrome in haemodialysis
patients. Nephrol. Dial. Transplant 19: 1507-1519, 2004.
523. Stolear J, Georges B, Shita A, Verbeelen D. The predictive
value of cardiac troponin T measurements in subjects on
regular hemodialysis. Nephrol Dial Transplant 14: 1961-67,
1999.
524. Ducloux D, Bresson-Vautrin C, Kribs M, Abdelfatah A,
Chalopin M. C-reactive protein and cardiovascular disease
in peritoneal dialysis patients. Kidney Int 62: 1417-22, 2002.
525. Herzig KA, Purdie DM, Chang W, Brown AM, Hawley CM,
Campbell SB, y cols. Is C-reactive protein a useful predictor
of outcome in peritoneal dialysis patients? J Am Soc
Nephrol. 12:814-21, 2001.
526. Spittle MA, Hoenich NA, Handelman GJ, Adhikarla R,
Homel P, Levin NW. Oxidative stress and inflammation in
hemodialysis patients. Am J Kidney Dis. 38:1408-13, 2001.
527. Varagunam M, Finney H, Trevitt R, Sharples E, McCloskey
DJ, Sinnott PJ, y cols. Pretransplantation levels of C-reactive
protein predict all-cause and cardiovascular mortality, but
not graft outcome, in kidney transplant recipients. Am J
Kidney Dis 43:502-7, 2004.
528. Pawlak K, Naumnik B, Brzosko S, Pawlak D, Mysliwiec
M.Oxidative stress - a link between endothelial injury, coagulation
activation, and atherosclerosis in haemodialysis
patients. Am J Nephrol. 24:154-61, 2004.
529. Bakri RS, Afzali B, Covic A, Sriskantharan R, Bharma-Ariza P,
Park WH, y cols. Cardiovascular disease in renal allograft
recipients is associated with elevated sialic acid or markers
of inflammation. Clin Transplant. 18:201-4, 2004.
530. Menon V, Wang X, Greene T, Beck GJ, Kusek JW, Marcovina
SM, y cols. Relationship between C-reactive protein, albumin,
and cardiovascular disease in patients with chronic kidney
disease. Am J Kidney Dis 42: 44-52, 295.
531. Ortega O, Rodriguez I, Gallar P, Carreno A, Ortiz M, Espejo
B, y cols. Significance of high C-reactive protein levels in
pre-dialysis patients. Nephrol Dial Transplant. 17:1105-9,
2002.
532. Papayianni A, Alexopoulos E, Giamalis P, Gionanlis L,
Belechri AM, Koukoudis P, y cols.Circulating levels of ICAM-
1, VCAM-1, and MCP-1 are increased in haemodialysis
patients: association with inflammation, dyslipidaemia, and
vascular events. Nephrol Dial Transplant. 17:435-41, 2002.
533. Papagianni A, Kalovoulos M, Kirmizis D, Vainas A, Belechri
AM, Alexopoulos E y cols.Carotid atherosclerosis is associated
with inflammation and endothelial cell adhesion molecules
in chronic hemodialysis patients. Nephrol Dial
Transplant. 18: 113-9, 2003.
534. Papagianni A, Kokolina E, Kalocvoulos M, Vainas A,
Dimitriadis C, Memmos D. Carotid atherosclerosis is associated
with inflammation, malnutrition and intercellular
adhesion molecule-1 in patients on continuous ambulatory
peritoneal dialysis. Nephrol Dial Transplant 2004 (en prensa)
535. Oh J, Wunsch R, Turzer BC y cols. Advanced coronary and
carotid arteriopathy in young adults with childhood-onset
chronic renal failure. Circulation 106: 100-105, 2002.
536. Leskinen Y, Groundstroem K, Virtanen V, Lehtimaki T,
Huhtala H, Saha H. Risk factors for aortic atherosclerosis
determined by transesophageal echocardiography in patients
with CRF. Am J Kidney Dis. 42:277-85, 2003.
537. Stenvinkel P, Heimburger O, Jogestrand T. Elevated interleukin-6
predicts progressive carotid artery atherosclerosis in
dialysis patients: association with Chlamydia pneumoniae
seropositivity. Am J Kidney Dis 39: 274–282, 2002
538. Cardiovascular risk extended evaluation in dialysis patients
research group (CREED): C-reactive protein and atherosclerosis
in dialysis patients. Nephrol Dial Transplant 13: 2710-
2711, 1998.
539. Pecoits-Filho R, Lindholm B, Stenvinkel P. The malnutrition,
inflammation and atherosclerosis (MIA) syndrome. The heart
of the matter. Nephrol Dial Transplant 17(supl 11): S28-S31,
2002.
540. Park CW, Shin YS, Kim CM, Lee SY, Yu SE, Kim SY, y cols.
Increased C-reactive protein following hemodialysis predicts
cardiac hypertrophy in chronic hemodialysis patients. Am J
Kidney Dis 40: 1230-39, 2002.
541. Stenvinkel P. Andersson P. Wang T, y cols. Do ACE-inhibitors
suppress tumour necrosis factor-alpha production in advanced
chronic renal failure ? J Int Med 246-503-7, 1999.
542. Chang JW, Yang WS, Min WK, Lee SK, Park JS, Kim SB.
Effects of simvastatin on high-sensitivity C-reactive protein
and serum albumin in hemodialysis patients. Am J Kidney
Dis. 39:1213-7, 2002.
543. Vernaglione L, Cristofano C, Muscogiuri P, Chimienti S.
Does atorvastatin influence serum C-reactive protein levels
in patients on long-term hemodialysis? Am J Kidney Dis. 43:
471-8, 2004.
544. Kim SB, Lee SK, Min WK, Chi HS, Park JS. Lack of effects of
low-dose aspirin on high-sensitivity C-reactive protein,
hemostatic factors, and troponin T in CAPD patients.Perit
Dial Int. 22:721-3, 2002.
545. Bloembergen WE, Hakim RM, Stannard DC, Held PJ, Wolfe
RA, Agodoa LY, y cols. Relationship of dialysis membrane
and cause-specific mortality. Am J Kidney Dis. 1999 ;33:1-
10.
546. Irish A. Cardiovascular disease, fibrinogen and the acute
phase response: associations with lipids and blood pressure
in patients with chronic kidney disease. Atherosclerosis 137:
133-9, 1998.
547. Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Parlongo S,
Malatino LS, y cols. Fibrinogen, mortality and incident cardiovascular
complications in end-stage renal failure. J Inter
Med 254: 132-139, 2003.
548. Koch M, Kutkuhn B, Grabensee B, Ritz E. Apolipoprotein A,
fibrinogen, age, and history of stroke are predictors of death
in dialysed diabetic patients: a prospective study in 412 subjects.
Nephrol Dial Transplant. 12:2603-11, 1997.
549. Freedman BI, Iskandar SS, Appel RG: The link between
hypertension and nephrosclerosis. Am J Kidney Dis 25: 207-
221, 1995.
550. Sociedad Española de Hipertensión - Liga Española para la
Lucha contra la Hipertensión Arterial (SEH-LELHA): Guía
sobre el diagnóstico y el tratamiento de la hipertensión arterial
en España 2002. Hipertensión 19 (suppl 3):1-74, 2002.
551. Jacobson HR: Ischemic renal disease: an overlooked clinical
entity? Kidney Int 34: 729-743, 1988.
552. Alcázar JM, Rodicio JL: Ischemic nephropathy: clinical characteristics
and treatment. Am J Kidney Dis 36: 883-893, 2000.
203